Lenvatinib Mesylate and Reyataz (Atazanavir Powder for Oral Suspension)
Determining the interaction of Lenvatinib Mesylate and Reyataz (Atazanavir Powder for Oral Suspension) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: atazanavir
Brand name: Reyataz
Synonyms: Reyataz
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Reyvow
- Lenvatinib Mesylate-Rezira
- Lenvatinib Mesylate-Rh(D) Immune Globulin
- Lenvatinib Mesylate-Rheumatrex
- Lenvatinib Mesylate-Rheumatrex Dose Pack
- Lenvatinib Mesylate-Rheumatrex Dose Pack Oral
- Reyataz (Atazanavir Powder for Oral Suspension)-Lenvima
- Reyataz (Atazanavir Powder for Oral Suspension)-Lenvima (14 MG Daily Dose)
- Reyataz (Atazanavir Powder for Oral Suspension)-Lenvima (18 MG Daily Dose)
- Reyataz (Atazanavir Powder for Oral Suspension)-Lenvima (20 MG Daily Dose)
- Reyataz (Atazanavir Powder for Oral Suspension)-Lenvima (24 MG Daily Dose)
- Reyataz (Atazanavir Powder for Oral Suspension)-Lenvima (8 MG Daily Dose)